http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2375359-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cbf2cb1a8739503221be551ed0f7c8d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2005-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a21186ae25b96521ba1bb84ce3f6f4d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8c9c5c6db6d1d2b1c9bc605d3c9edbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_549c2a4dc46ec8039bc45219405406d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c313007ce27d2c5bb44ba0e8927ff3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9799fa5585091857d49353f985dedcaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9196f521a9b883c7d36f79f0652ceaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6039b1af1beaa92d4e113f87083e824 |
| publicationDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2375359-C2 |
| titleOfInvention | PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND METHODS FOR MAKING THEREOF |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to new derivatives of pyrrolo[3,2-c]pyridine of general formula (I) n where R 1 represents hydrogen; linear or branched C 1 -C 6 alkyl group optionally substituted with one or more substitutes chosen from the group consisting of C 1 -C 5 alkoxy, C 3 -C 7 cyclalkyl, 1,3-dioxolanyl, cyano, naphtyl, C 2 -C 5 alkenyloxy and 2,3-dihydrobenzo[1,4]dioxinyl; C 2 -C 6 alkenyl group; C 2 -C 6 alkinyl group; or benzyl group optionally substituted with one or more substitutes chosen from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 alkoxy, cyano, C 1 -C 3 alkoxycarbonyl and trifluoru-C 1 -C 3 alkyl, R 2 represents linear or branched C 1 -C 6 alkyl group, R 3 represents hydrogen; linear or branched C 1 -C 6 alkyl group optionally substituted with hydroxyl or cyano, and R 4 represents 1,2,3,4-tetrahydroisoquinolinic group optionally substituted with one or more halogens or C 1 -C 5 alkyls; benzyloxy-group optionally substituted with one or more halogens or C 1 -C 5 alkyls; or benzylamino group optionally substituted with halogen, and also to the method for making thereof and the pharmaceutical composition inhibiting proton pump. n EFFECT: there are produced and disclosed new compound with inhibitory action on the proton pump and ability to ensure reversible inhibitory effect of the proton pump. n 7 cl, 45 ex, 2 tbl |
| priorityDate | 2004-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.